Large Burns
≥30% TBSA
Vericel websites use cookies, small text files stored on your browser, to personalize your web experience and to analyze website traffic. By continuing to use this website without changing your settings, you are agreeing to our use of cookies and to our collection of information. For more information about what Vericel collects and how we use it, visit our Privacy Policy.
In the Epicel Clinical Experience databases, 453 patients showed a median take rate at discharge of 75%1
Epicel is indicated for adult and pediatric patients who have deep dermal or full thickness burns comprising a total body surface area greater than or equal to 30%
Large Burns
≥30% TBSA
Epicel is widely reimbursed and included on a majority of national insurance plans.
Click here to learn more about Epicel reimbursement